Go2 Foundation for Lung Cancer-fka Lca- on Behalf of Deadliest Cancers Coalition
lung cancer advocacy
Based in DC
AI Overview
With $225K in lobbying spend across 33 quarterly filings, Go2 Foundation for Lung Cancer-fka Lca- on Behalf of Deadliest Cancers Coalition is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $0 |
| 2019 | $50K |
| 2020 | $60K |
| 2021 | $50K |
| 2022 | $30K |
| 2023 | $20K |
| 2024 | $15K |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Go2 Foundation for Lung Cancer-fka Lca- on Behalf of Deadliest Cancers Coalition disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Medicare/Medicaid, MED
Advocating on behalf of the deadliest cancers, which are defined as those with a five-year survival rate below 50 percent.
Funding for NCI in the FY19 Labor, Health & Human Services, and Education Appropriations bills
Report language on deadliest cancers in the FY19 Labor, Health & Human Services, and Education Appropriat
Medicare Part B proposals outlined in President Trumps Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs and corresponding Request for Information (RFI)
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.